Tumor mRNA-pulsed autologous Dendritic Cells (TTRNA-DCs)
Showing 1 - 25 of >10,000
Alzheimer Trial (ALZN002 (autologous DCs pulsed with E22W mutant peptide)., Placebo)
Not yet recruiting
- Alzheimer Disease
- ALZN002 (autologous DCs pulsed with E22W mutant peptide).
- Placebo
- (no location specified)
Apr 17, 2023
Melanoma Trial in New York (Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs))
Completed
- Melanoma
- Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 12, 2023
Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria
Suspended
- Glioblastoma
- Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
- +4 more
-
Durham, North CarolinaDuke University Medical Center
Aug 16, 2022
Glioblastoma Trial in Gainesville (Autologous DCs derived from PBMC loaded with RNA encoding the human CMV matrix protein
Recruiting
- Glioblastoma
- Autologous DCs derived from PBMC loaded with RNA encoding the human CMV matrix protein pp65-flLAMP plus GM-CSF
-
Gainesville, FloridaUniversity of Florida Health Shands Hospital
Apr 29, 2022
Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma Trial in Durham (Unpulsed DCs, Td, Human CMV pp65-LAMP mRNA-pulsed
Completed
- Glioblastoma
- +3 more
- Unpulsed DCs
- +6 more
-
Durham, North CarolinaDuke University Medical Center
Jan 3, 2022
Neuroblastoma, Diffuse Intrinsic Pontine Glioma Trial in Gainesville, Charlotte (Tumor-specific ex vivo expanded autologous
Recruiting
- Neuroblastoma
- Diffuse Intrinsic Pontine Glioma
- Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT)
-
Gainesville, Florida
- +1 more
Apr 20, 2022
Glioblastoma Multiforme, Glioblastoma, Malignant Glioma Trial in Gainesville, Orlando, Durham (pp65-shLAMP DC with GM-CSF,
Recruiting
- Glioblastoma Multiforme
- +4 more
- pp65-shLAMP DC with GM-CSF
- +4 more
-
Gainesville, Florida
- +2 more
Jan 6, 2022
Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma Trial in Gainesville (TTRNA-DC vaccines with GM-CSF, TTRNA-xALT,
Recruiting
- Diffuse Intrinsic Pontine Glioma (DIPG)
- Brain Stem Glioma
- TTRNA-DC vaccines with GM-CSF
- +5 more
-
Gainesville, FloridaUF Health Shands Children's Hospital
Apr 29, 2022
Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard
Completed
- Glioblastoma
- +4 more
- Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
- Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Nov 18, 2021
Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma Trial in Los Angeles (tumor lysate-pulsed autologous
Completed
- Adult Diffuse Astrocytoma
- +4 more
- tumor lysate-pulsed autologous dendritic cell vaccine
- laboratory biomarker analysis
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Oct 14, 2020
Malignant Glioma, High Grade Glioma Trial in Birmingham, Washington, Gainesville (TTRNA-DC vaccines with GM-CSF,
Recruiting
- Malignant Glioma
- High Grade Glioma
- TTRNA-DC vaccines with GM-CSF
- +4 more
-
Birmingham, Alabama
- +2 more
Feb 2, 2023
Giant Cell Glioblastoma, Gliosarcoma, Oligodendroglioma Trial in Los Angeles (autologous dendritic cells pulsed with tumor
Withdrawn
- Giant Cell Glioblastoma
- +4 more
- autologous dendritic cells pulsed with tumor lysate antigen Vaccine
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 22, 2020
Brain Cancer, Tumor Metastases Trial in Guangzhou (Personalized cellular vaccine)
Completed
- Brain Cancer
- Neoplasm Metastases
- Personalized cellular vaccine
-
Guangzhou, Guangdong, ChinaGuangdong 999 Brain Hospital
May 23, 2022
Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)
Completed
- Stage III Malignant Melanoma of Skin AJCC V6
- Stage IV Malignant Melanoma of Skin
- TAPCells vaccine
-
Santiago, RM, ChileFaculty of Medicine, University of Chile
Nov 21, 2023
Malignant Melanoma, Adjuvant Drug Therapy, Vaccin Therapy Trial in Meldola (FC), Meldola (Autologous Dendritic Cell vaccine)
Terminated
- Malignant Melanoma
- +2 more
- Autologous Dendritic Cell vaccine
-
Meldola (FC), FC, Italy
- +1 more
Apr 20, 2020
Metastatic Melanoma Trial (PV-001-DC)
Not yet recruiting
- Metastatic Melanoma
- PV-001-DC
- (no location specified)
Aug 4, 2022
Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)
Not yet recruiting
- Angiosarcoma
- Paclitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 23, 2023
Glioblastoma Trial in Guangzhou (Personalized cellular vaccine)
Completed
- Glioblastoma
- Personalized cellular vaccine
-
Guangzhou, Guangdong, ChinaGuangdong 999 Brain Hospital
May 23, 2022
Glioblastoma Multiforme of Brain Trial in Beijing (Autologous dendritic cells pulsed with multiple neoantigen peptides.,
Recruiting
- Glioblastoma Multiforme of Brain
- Autologous dendritic cells pulsed with multiple neoantigen peptides.
- Temozolomide adjuvant chemotherapy
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Jan 13, 2022
Brain and CNS Tumors Trial in Los Angeles (therapeutic autologous dendritic cells)
Completed
- Brain and Central Nervous System Tumors
- therapeutic autologous dendritic cells
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020
Ovarian Carcinoma Trial (PEP-DC1, OC-DC, PEP-DC2)
Not yet recruiting
- Ovarian Carcinoma
- PEP-DC1
- +3 more
- (no location specified)
Jan 26, 2023
Brain and CNS Tumors Trial in Los Angeles (therapeutic autologous dendritic cells)
Completed
- Brain and Central Nervous System Tumors
- therapeutic autologous dendritic cells
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Aug 3, 2020
Mesotheliomas Pleural Trial in Rotterdam (Mesopher)
Recruiting
- Mesotheliomas Pleural
- Mesopher
-
Rotterdam, Zuid Holland, NetherlandsErasmus MC
Mar 22, 2022
Melanoma, Uveal Metastatic Trial in Erlangen (Vaccination with IKKb matured Dendritic Cells)
Active, not recruiting
- Melanoma, Uveal Metastatic
- Vaccination with IKKb matured Dendritic Cells
-
Erlangen, Bavaria, GermanyUniversity Hospital Erlangen Dept. of Dermatology
Mar 16, 2022
Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,
Not yet recruiting
- Malignant Pleural Mesothelioma
- Dendritic cell vaccination
- +2 more
-
Edegem, Antwerp, Belgium
- +2 more
Feb 28, 2023